Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

about

Amphotericin B in lipid emulsion: stability, compatibility, and in vitro antifungal activity.Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.

P2860

Q33692176-63223760-4649-4DF7-9A1A-0D6317A84B7C Q38077678-0FDF99A7-96A2-4BAB-9508-5DBF62F0E41D

P2860

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

Item

http://www.wikidata.org/entity/Q35891310

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@ast

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@en

type

Item

label

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@ast

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@en

prefLabel

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@ast

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@en

P1476

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

@en

P2093

C Rotstein

http://www.w3.org/2001/XMLSchema#string

S Salama

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of creatinine clearance from serum creatinine

Amphotericin B: 30 years of clinical experience.

Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics.

The emergence of fungi as major hospital pathogens.

Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.

Itraconazole: a new triazole antifungal agent.

Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.

New methods of delivery of amphotericin B.

The future of antifungal therapy.

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.

P304

157-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/1997/827297

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1997-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22514488

http://www.w3.org/2001/XMLSchema#string

P932

3327353

http://www.w3.org/2001/XMLSchema#string

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

about

P2860

P2860

Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932